manufacturer deliberately shorted the Medicaid program by leaving retroactive drug price increases out of the metrics it was required to include for drug rebate calculations. Siding with relator Ronald Streck, the jury found that Eli Lilly knowingly made a false claim, record or statement to the government, that the false claim was material and that the company's false claims proximately caused the government's losses under a rebate program the company entered in 1991. The verdict ends the trial in Streck's 2014. . .
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
A waste disposal company won dismissal of a False Claims Act suit alleging it improperly billed the federal and Montana governments for services it didn’t provide. Whistleblowers Max Bauer Jr. and...